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U.S. regulatory and research agencies use ecotoxicity test data to assess the hazards associated with substances
that may be released into the environment, including but not limited to industrial chemicals, pharmaceuticals,
pesticides, food additives, and color additives. These data are used to conduct hazard assessments and evaluate
potential risks to aquatic life (e.g., invertebrates, fish), birds, wildlife species, or the environment. To identify
opportunities for regulatory uses of non-animal replacements for ecotoxicity tests, the needs and uses for data
from tests utilizing animals must first be clarified. Accordingly, the objective of this review was to identify the
ecotoxicity test data relied upon by U.S. federal agencies. The standards, test guidelines, guidance documents,
and/or endpoints that are used to address each of the agencies’ regulatory and research needs regarding eco
toxicity testing are described in the context of their application to decision-making. Testing and information use,
needs, and/or requirements relevant to the regulatory or programmatic mandates of the agencies taking part in
the Interagency Coordinating Committee on the Validation of Alternative Methods Ecotoxicology Workgroup are
captured. This information will be useful for coordinating efforts to develop and implement alternative test
methods to reduce, refine, or replace animal use in chemical safety evaluations.
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Aquatic toxicology
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Ecotoxicity testing
New approach methodologies
Non-animal methods
Regulatory requirements
U.S. federal agencies
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Technology (NIST), develop and use reference materials and standards
related to measurements of environmental quality.
To carry out these activities, the federal agencies determine the
hazards and risks presented by substances that may enter the environ
ment, including but not limited to industrial chemicals, pharmaceuti
cals, pesticides, food additives, and color additives. Where critical data
are absent, agencies use standardized ecotoxicity tests to assess hazard,
risk, and environmental impacts. These tests are currently performed on
live organisms using U.S. standardized and internationally harmonized
test methods. Such testing has been the backbone of chemical safety
assessments for decades and has served the purpose of gaining an un
derstanding of chemical toxicities to inform regulatory decision-making.
Ecotoxicity tests include a broad spectrum of procedures, with
differing species, exposure media, and effects measurements. In this

1. Introduction
Multiple agencies of the United States (U.S.) federal government are
charged with protecting human and animal health, natural resources,
and/or the environment (16 U.S.C. § 661-667e, 1934; Fairbrother, 2009)
and/or assessing the impact of human activity on the environment (42
U.S.C. § 4321 et seq., 1969). These agencies include, but are not limited
to, the U.S. Department of Defense (DOD), U.S. Department of the
Interior (DOI), U.S. Environmental Protection Agency (EPA), U.S. Food
and Drug Administration (FDA), National Institute of Environmental
Health Sciences (NIEHS), and the U.S. Department of Agriculture
(USDA). Other agencies, like the National Institute of Standards and
2
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context, the standard ecological toxicity tests can be used to demonstrate
whether contaminants are bioavailable, assess toxic effects of individual
chemicals and the aggregate toxic effects of all contaminants in a me
dium (e.g., discharged effluent from a facility into a receiving water),
and can characterize the nature of a toxic effect on the organism (e.g.,
survival, reduced growth, impaired reproduction, and behavioral
changes).
For the most part, the vast array of aquatic toxicity tests is highly
standardized, straightforward to conduct, and have been widely used
since the 1970s, while standardized sediment toxicity test procedures
must also consider bioavailability in different sediment types. Soil
testing with invertebrates and standard soils is well established, but
higher order terrestrial organism tests with plants and vertebrates are
more difficult and more expensive to conduct. Results generated from
these standardized tests are used for many regulatory practices such as
evaluating new chemical registration, evaluating potential toxicity of
existing chemicals in commerce, developing remedial goals, application
in developing water quality criteria, and monitoring in the environment.
Although these tests have proven to be useful for informing U.S. regu
latory decision-making, tests in vertebrates and invertebrates used for
evaluating chemical product registrations are resource intensive and
raise ethical concerns associated with using animals for this purpose.
Given the large number of chemicals produced each year, it is difficult to
keep pace with chemical safety evaluations using these traditional test
methods which have long been recognized as a limitation for risk as
sessments due to advances in the development and rapid production of
new chemistries.
Furthermore, test methods are developed and standardized with
specific organisms that have been selected to serve as model organisms,
typically chosen for their availability, adaptability to laboratory testing,
potential to be tested at different life stages, low-cost of maintenance,
historical data, their potential to serve as representatives of broader
populations and life cycles. The choice of model species should consider
their “domain of applicability” and conservation or the sharing of
toxicity-relevant biological traits between model species and ecological
target species” (Segner and Baumann, 2016). This remains a challenge in
the use of model organisms in toxicity testing where it is traditionally
assumed that the test organism is representative of other species based
on a qualitative understanding of species relatedness.
The focus of this paper is to identify U.S. federal agency applications,
the need for, and/or requirements for ecotoxicity testing methods. The
identification of the routinely used methods in ecotoxicology is an
important step toward identifying and prioritizing potential tests or
toxicities that may be targeted for developing alternative methods. This
review was prepared by the Ecotoxicology Workgroup (EcoWG) under
the Interagency Coordinating Committee on the Validation of Alterna
tive Methods (ICCVAM) (National Toxicology Program, 2021a). Among
ICCVAM’s member agencies are those that have statutory mandates to
protect the environment and biota such as plants, invertebrates, fish,
and wildlife, including threatened and endangered species, as well as
agencies interested in assessing the effects of chemicals on diverse spe
cies as part of broader research or operational goals.
Many of the tests used to assess hazard and risk are currently per
formed on live organisms and may cause pain or distress. Federal fa
cilities conducting ecotoxicity testing are required to comply with the
regulatory requirements and guidelines for humane animal care
depending on species and funding. These include but are not limited to:
the Animal Welfare Act (AWA (7 U.S.C. § 2131 et seq., 2012),); U.S.
Government Principles for the Utilization and Care of Vertebrate Ani
mals Used in Testing, Research, and Training (NIH OLAW, 2018); the
Public Health Service Policy on Humane Care and Use of Laboratory
Animals (Office of Laboratory Animal Welfare, 2015); the “Guide for the
Care and Use of Laboratory Animals” (National Research Council,
2011); and the “Guide for the Care and Use of Agricultural Animals in
Research and Teaching” (Federation of Animal Science Societies, 2010).
An Institutional Animal Care and Use Committee (IACUC) has

oversight of the live animal work under the AWA, PHS policy, and other
applicable regulations and guidelines. The IACUC reviews and approves
work conducted with live animals. As part of the process, the IACUC has
imperatives to ensure pain and distress are minimized as much as
scientifically justifiable while accomplishing ecotoxicity testing needs
(Carbone, 2011, 2019). The IACUC is also required to ensure alterna
tives to procedures that cause greater than momentary or slight pain/
distress are considered by the Principal Investigator (9 CFR § 2.31 (d)(1)
(ii), 2004).
Ecotoxicology work with wildlife species may also require compli
ance with the other Federal regulations such as the Endangered Species
Act; and compliance with State regulations to obtain permits.
An approach to toxicity testing envisioned to be more efficient,
predictive, and economical than animal use was proposed over a decade
ago by the National Research Council (National Research Council, 2007,
and has gained international support (Andersen and Krewski, 2009;
Krewski et al., 2014). This approach, which uses in chemico, in vitro, and
in silico new approach technologies/methodologies (NAMs) that can
inform hazard and risk assessments, has been adopted by the U.S.
Interagency Toxicology in the 21st Century (Tox21) Consortium (Tox 21
Consortium, 2020). Use of NAMs is gaining acceptance for some regu
latory testing applications including endocrine activity (U.S. EPA,
2015a) and skin sensitization (U.S. EPA, 2018).
U.S. government activities to support the development of NAMs and
increase confidence in their use for a broad range of U.S. regulatory
needs are being guided by the 2018 “Strategic Roadmap for Establishing
New Approaches to Evaluate the Safety of Chemicals and Medical
Products in the United States”. Development of the Strategic Roadmap
was coordinated by ICCVAM. ICCVAM facilitates the development,
validation, and regulatory acceptance of NAMs and other approaches
that replace, reduce, or refine (Russell and Burch, 1992; Tannenbaum
and Bennett, 2015). ICCVAM membership is comprised of 17 U.S. fed
eral agencies that use, generate, or disseminate toxicological and safety
testing information(National Toxicology Program, 2021b). ICCVAM’s
EcoWG is actively pursuing the application of NAMs to ecotoxicity
testing scenarios.
The Strategic Roadmap (ICCVAM, 2018a) describes three goals to be
addressed in development and implementation of NAMs:
• Connecting end-users with the developers of NAMs,
• Fostering the use of efficient, flexible, and robust practices to
establish confidence in new approach methods, and
• Encouraging the adoption and use of NAMs and other approaches by
federal agencies and regulated industries.
To address the goals of the Strategic Roadmap, implementation plans
for toxicity areas are developed (ICCVAM, 2018b). While such sum
maries of testing and information needs have been developed for
nanomaterials (Petersen et al., 2021), human acute systemic toxicity
(Strickland et al., 2018), skin and eye irritation (Choksi et al., 2019), and
skin sensitization (Strickland et al., 2019), no such summary exists for
ecotoxicity.
In this paper, the EcoWG (which is sponsored by DOD, DOI, and EPA,
and includes representatives from these agencies as well as from FDA,
NIEHS, NIST, and USDA) defines specific ecotoxicity testing and infor
mation gathering approaches relevant to the regulatory or program
matic mandates of the agencies participating in the EcoWG. This
summary is not intended to be a compendium of all statutes which
require testing, or all test methods used to evaluate toxicity to ecosys
tems, nor is it intended to be a complete survey of all U.S. agencies,
offices, or divisions that require or utilize ecotoxicity testing. However,
by collating this information, we believe that the U.S. and international
efforts to develop and implement alternative methods for ecotoxicity
testing will be enhanced, along with harmonization of ecotoxicity
testing and regulatory requirements.
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endpoint groups (e.g., acute toxicity, bioaccumulation, etc.), and taxa (e.
g., amphibian, avian, fish, etc.). Table 2 represents the number of tests
per endpoint that use representatives of a given taxa. Chronic/Growth/
Reproduction and Acute toxicity tests in invertebrates, fish, pollinator,
and avian species are most commonly requested across the U.S. federal
agencies, followed by bioaccumulation tests which use organisms in
diverse taxa. EPA requests the majority of ecotoxicity test data con
ducted using the guidelines listed in Table S2.
There are a variety of testing and information requirements based on
diverse scenarios addressing different agency needs. These differing
needs are discussed in the subsequent sections.

Table 1
U.S. statutes and regulations which consider ecotoxicology test data and appli
cable agencies.
U.S. statute/regulationa

Abbreviation

Applicable
Agency

Animal Damage Control Actb
Bald and Golden Eagle Protection Act
Comprehensive Environmental Response,
Compensation and Liability Act
Clean Water Act
Endangered Species Act

ADC
BGEPA
CERCLA

DOI, USDA
DOI, USDA
DOD, DOI, EPA

CWA
ESA

Federal Insecticide, Fungicide, and Rodenticide
Act
Federal Land Policy and Management Act of
1976
Food Quality Protection Act
General Mining Act of 1872
Marine Protection, Research and Sanctuaries Act
Migratory Bird Treaty Act
National Environmental Policy Act

FIFRA

DOD, DOI, EPA
DOI, EPA,
USDA
DOI, EPA,
USDA
DOI

National Wildlife Refuge System Administration
Act
Oil Pollution Act of 1990
Outer Continental Shelf Lands Act
The Organic Act Establishing the U.S. Geological
Survey as a Research Entity
Toxic Substances Control Act

FLPMA
FQPA
GMA
MPRSA
MBTA
NEPA
NWRSAA

EPA
DOI
DOD
DOI
DOI, FDA,
USDA
DOI

OPA
OCLSA
None

DOD, DOI, EPA
DOI
DOI

TSCA

EPA, USDA

2.1. U.S. Department of Defense
2.1.1. Department of the Air Force
The Air Force performs natural and cultural resource management
and evaluates environmental stressors under authority of the Compre
hensive Environmental Response, Compensation, and Liability Act
(CERCLA (42 U.S.C. § 9601 et seq., 1980);); Clean Water Act (CWA (33
U.S.C. § 1251–1387, 1972);); the National Environmental Policy Act
(NEPA; (42 U.S.C. § 4321 et seq., 1969); the Oil Pollution Act (OPA; (33
U.S.C. § 2701 et seq, 1990)); and the Resource Conservation and Re
covery Act (42 U.S.C. § 6901 et seq., 1976) (Table 1).
The Air Force evaluates potential threats and impacts to human
health and the environment for emerging contaminants through the
Environmental Impact Analysis Process (32 CFR § 989, 1999). The
challenge with the Air Force’s ecotoxicity needs is that they are specific
to individual bases, sites, and scenarios.

a

Copies of the laws cited in this table can be obtained from web locations
available in Table S1.
b
On August 1, 1997, the Animal Damage Control program was officially
renamed to Wildlife Services (Hawthorne, 2004).

2.1.2. Department of the army
The Army has many needs for understanding the toxicity of envi
ronmental stressors on ecological species (CERCLA, OPA, NEPA, and
CWA Table 1).
The Army uses ecotoxicity testing to understand the potential haz
ards of new materials, including energetic compounds, compounds used
in signaling and obscurants, and nanomaterials. The specific compounds
and tests to be performed are determined on a case-by-case basis
depending on the needs and the potential uses. Ecotoxicity testing can
also be required for site assessment, which is also determined on a caseby-case basis. An example of Army ecotoxicity activities would be the
evaluation of dredged material proposed for disposal under the Marine
Protection, Research and Sanctuaries Act to prevent toxicity and bio
accumulation that could affect human health and the environment (33
U.S.C. §1401 et seq., 1988). There are other uses for ecotoxicity data
within the military mission; however, these are very specific to those
programs and those needs may change on an ongoing basis.
The Army performs natural resource damage assessments (U.S.
Army, 2020) to identify natural resource injuries (NRI) that are regu
lated under CERCLA, OPA, and CWA. A NRI is defined as any adverse
and measurable change to a natural resource, where the term natural
resource is defined to include land, fish, wildlife, biota, water, air,
groundwater, drinking water supplies, and other similar resources. This
definition creates a nexus with the Endangered Species Act (ESA; (U.S.
EPA, 2014a)) when the NRI may involve or affect threatened and

2. Use of ecotoxicity data by select U.S. federal agencies
EcoWG members were surveyed to determine which statutes,
guidelines, and methods were relevant to their agencies. Responses
included tests conducted in single celled organisms such as algae and
cyanobacteria as well as plants. Since one of the objectives of this
document is to identify opportunities for regulatory uses of non-animal
replacements for ecotoxicity tests, single celled organismal and plant
tests were not included in the detailed results of that survey which are
provided in the supplemental materials (Tables S1 and S2) and are
summarized in Table 1 and Table 2. Eighteen different U.S statutes were
identified that either require or make use of ecotoxicity data (Table 1).
While several of these statutes govern the activities of a single agency,
others are more broadly applicable to the activities of multiple federal
agencies. To address these statutory requirements, an even greater
number of U.S. and international ecotoxicity test guidelines and guid
ance documents have been developed. These tests include invertebrates
and vertebrates (Table 2), and the majority are used to identify risks to
aquatic, avian, or terrestrial organisms. Further details of the statutes
and regulations under which these tests are carried out, along with the
scope and endpoints measured by each of the tests are included in
Table S1.
The test guidelines in Table S2 are broadly divided into toxicity
Table 2
Number of test guidelines by type/taxa.
Test Typea
Acute
Bioaccumulation
Chronic/Growth/Reproduction
Field testing
Microcosm
Number of Test Guidelines by Taxa

Amphibians

Aves

Bees

Fish

Invertebrates

Mammals

2

4

3

2
2

12
2
25

2

4

7
2
14

4

5

8

23

39

8

a

6

Cross-taxa
1
2
3
6

Number of Test Guidelines by Test Type
27
5
54
4
3

The numbers presented for each taxa represent the number of test guidelines per test type that use members of the specified taxa, e.g., there are two acute toxicity
test guidelines that use mammals.
4
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endangered species directly or indirectly.
As noted for the Air Force, the Army’s ecotoxicity assessment needs
tend to be scenario specific. For instance, the Army may want to develop
a training area for long-range precision fires (e.g., artillery). To do that,
the Army will study the natural resources in the area and determine
whether these new activities will result in a nuisance or hazard to any
existing threatened and endangered species. The Army seeks to limit its
liability under CERCLA, which establishes responsibility for remediation
of releases of chemicals that may affect public health or the environ
ment. As a result, the Army will need to perform some ecotoxicity testing
to ascertain the level of injury that may result to species of concern. With
threatened and endangered species, this becomes even more chal
lenging, as there may not be enough animals to use for testing without
causing a significant impact to the existing population. However, in rare
instances testing may be undertaken with appropriate permissions.
Thus, any alternatives to the use of animals will help fill knowledge gaps
that may not be filled through species extrapolation from currently
available test methods.

model invertebrate, fish, and wildlife species to determine actual versus
perceived hazard of a range of environmental contaminants (e.g., pes
ticides, industrial compounds, pharmaceuticals, metals). Such studies
use statistical methods and designs to minimize the number of animals,
frequently incorporating sublethal and minimally invasive endpoints to
obtain comprehensive toxicity and mechanistic data. Some endpoints
require whole animal tests (e.g., avian eggshell thinning, flight ener
getics). However, several ongoing activities use cell-based or early lifestage systems for which test species are not classified as animals by
current statutes. In addition, DOI undertakes field biomonitoring efforts
with invertebrates, fish, and wildlife to obtain exposure and effects data
on natural resources in various settings where the potential for pollution
is substantial. Such field biomonitoring studies often utilize sublethal,
minimally-invasive and even non-invasive sampling from biota to assess
exposure and adverse effects.
DOI also has responsibility for restoring and preserving fish and
freshwater mussel populations in the United States and has a nationwide
system of hatcheries to carry out this responsibility. Research and
product approval activities on therapeutic agents for use in aquaculture
have been undertaken in the past. The array of laboratory studies and
clinical field trials required for product approval by FDA can be costly to
undertake and market demand is limited. There is, however, an ongoing
effort for development of pest and invasive fish control agents that seeks
to replace traditional toxicity tests using whole fish assays with a highthroughput alternative to screen compounds. This effort entails an initial
in silico step of pre-screening a chemical databank to select molecules
possessing characteristics identified as predictive criteria for potential
toxicity to various species of fish, followed by cytotoxicity screening in
fish cell lines. This two-stage procedure is being used to identify speciesspecific candidates for detailed animal or acceptable alternative
methods testing.

2.2. U.S. Department of the interior
The mission of the DOI is broad and includes the generation of sci
entific information to assist in the conservation and management of the
nation’s natural resources. DOI acts as the steward of roughly 20% of the
Nation’s lands through management of national parks, wildlife refuges,
and other land management units. Of its nine technical bureaus, at least
two conduct ecotoxicity tests (U.S. Geological Survey, U.S. Fish and
Wildlife Service), and others (e.g., Bureau of Land Management, Bureau
of Reclamation, National Park Service) either conduct ecotoxicity tests
directly or indirectly use such data in natural resource management
decisions.
Part of its stewardship responsibility requires DOI to play a major
role in the management of fish, wildlife, and threatened and endangered
species. DOI conducts a wide array of ecotoxicological research, damage
assessment, restoration, and registration studies under no fewer than 20
statutes and regulations. The primary drivers of these activities are
CERCLA, migratory bird hunting regulations (16 U.S.C. § 703, 1918; 50
CFR § 20.134, 1996), the Bald and Golden Eagle Protection Act (16 U.S.
C. § 688-688d, 2018), NEPA, OPA, CWA, ESA (Table 1), and the Surface
Mining Control and Reclamation Act (30 U.S.C. § 1201-1328, 1977; DOI,
2018).
Under CERCLA, CWA, and the OPA, the DOI Natural Resource
Damage Assessment and Restoration Program (DOI, 2015) identifies
injury to resources. Activities include (but are not limited to) bio
monitoring for contaminant exposure and potential adverse effects in
field settings and detailed toxicological characterizations of environ
mental contaminants and polluted matrices (e.g., water, sediment,
effluent, soil) in controlled exposure studies with invertebrates, fish, and
wildlife. The data generated are used by the Department of Justice in
establishing claims upon a responsible party and determining the nature
of restoration, rehabilitation, replacement, or acquisition of the equiv
alent, of the natural resources.
DOI has regulatory authority for registration of alternative shot and
shot-coatings that replace the highly toxic lead historically used in the
hunting of waterfowl and coots (DOI, 2013; Perry et al., 1997). The
tiered-testing protocol conducted by registrants generates data that are
submitted for review to the U.S. Fish and Wildlife Service at various
stages of the approval process. The protocol incorporates concepts of
reduced animal use in the testing, review, and registration process, as
existing data can be used to approve the candidate shot or shot-coating
for use.
In view of the uncertainty in extrapolating potential adverse effects
of contaminants among taxa (see Section 3.1), DOI and in particular the
U.S. Geological Survey, undertakes exposure and effects studies with

2.3. U.S. Environmental Protection Agency
EPA administers several environmental statutes to ensure protection
of human health and the environment and is responsible for maintaining
and enforcing national standards under applicable environmental laws
and working with states and tribes who enforce state and tribal laws (U.
S. EPA, 2013a). The two primary offices within EPA that implement
environmental statutes for which toxicity data generated on ecological
species are considered and, in some cases, required to meet regulatory
requirements are the Office of Chemical Safety and Pollution Prevention
(OCSPP) and the Office of Water (OW). Together, these offices work to
protect the environment from potential risks from pesticides, toxic
chemicals, and other compounds. The laws that are important drivers of
ecological effects testing include: the Federal Fungicide, Insecticide, and
Rodenticide Act (7 U.S.C. § 136 et seq, 1996)(FIFRA), the Toxic Sub
stances Control Act (TSCA (15 U.S.C. § 2601 et seq., 2016);), and the
Clean Water Act (33 U.S.C. § 1251 101 (a) et seq, 1972; 33 U.S.C. § 1251
102 et seq, 1972). In addition, the 1996 Food Quality Protection Act
(FQPA (7 U.S.C. § 136, 1996);), amendments to the Federal Food, Drug,
and Cosmetic Act (FFDCA (21 U.S.C. §301 et seq, 2002);), and the Safe
Drinking Water Act (SDWA (42 U.S.C. § 201, 1996; 42 U.S.C. § 300f,
1974);) mandate that EPA screen chemicals for endocrine activity,
which includes, at some screening tiers, whole animal ecotoxicity tests.
To conduct this screening, EPA established the Endocrine Disruptor
Screening Program (EDSP).
EPA program-specific ecotoxicity testing needs are described in more
detail below. EPA’s Office of Research and Development (ORD) devel
oped the Agency’s test procedures detailed in Title 40 of the Code of
Federal Regulations (CFR) Part 136.3 (40 CFR § 136.3, 2002) and in final
published guidance toxicity test methods. In some cases, these were
reviewed by EPA Headquarters’ (EPA-HQ) Office of Water and EPA
Regional offices. These methods are used by the Office of Water,
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including for regulation. While EPA ORD is not responsible for admin
istering any environmental laws, it does use ecotoxicity data and may
conduct in vivo testing for a variety of programs as well as for the
development of NAMs as animal alternatives and validation of those
methods.

OPP is also responsible for developing, maintaining, and evolving the
EDSP with the goal to screen chemicals for potential endocrine bioac
tivity and interactions with hormone systems in humans and other
nontarget vertebrate organisms. EPA utilizes a two-tiered screening
approach. The Tier 1 battery of assays consists of five in vitro and six in
vivo assays, four conducted in a model rat species, one conducted in a
model fish species, and one conducted in a model amphibian species (U.
S. EPA, 2008). Tier 2 consists of three non-mammalian test guidelines,
which complete the 890 test guideline series, and also utilizes two
existing mammalian test guidelines (U.S. EPA, 2015b).
There remain five in vivo Tier 1 assays without proposed NAMs
(Table S2), which assess male rat reproductive toxicity (U.S. EPA,
2009a), female and male rat sexual maturation (U.S. EPA, 2009b;
2009c), fish reproduction (U.S. EPA, 2009d), and amphibian develop
ment (U.S. EPA, 2009e). Also included in Table S2 are all the Tier 2 tests,
which include three non-mammalian 890 test guidelines (890.2100
Avian Two-Generation Toxicity Test in the Japanese Quail (U.S. EPA,
2015d), 890.2200 Medaka Extended One Generation Reproduction Test
(U.S. EPA, 2015h), and 890.2300 Larval Amphibian Growth and
Development Assay (U.S. EPA, 2015c)) and both mammalian test
guideline options (EPA 870.3800 Reproduction and Fertility (U.S. EPA,
1998), and OECD 443 Extended One-Generation Reproductive Toxicity
Study (OECD, 2018)). EPA may also accept other scientifically relevant
information in lieu of 890 test guidelines to inform Tier 2 testing needs
(U.S. EPA, 2009f).
EPA remains committed to and focused on the goals of the EDSP21
Work Plan to develop, validate, and adopt NAMs to screen chemicals for
endocrine bioactivity faster and better, with lower cost and the use of
fewer animals, while remaining protective of human and wildlife health
(U.S. EPA, 2011).

2.3.1. Office of chemical safety and Pollution Prevention
OCSPP implements FIFRA and TSCA, as well as sections of FFDCA,
via its program offices and uses ecological effects data in its regulatory
decision-making. OCSPP program offices with ecotoxicity testing needs
include the Office of Pesticide Programs (OPP) and the Office of Pollu
tion Prevention and Toxics (OPPT).
2.3.1.1. Office of Pesticide Programs. OPP uses toxicity data in its
ecological risk assessments to inform pesticide registration decisions and
determinations of the effects of regulatory decisions on nontarget or
ganisms including federally listed threatened and endangered species
(U.S. Fish and Wildlife Service, 2020) under the ESA. OPP’s procedures
for conducting pesticide risk assessments are described in the “Overview
of the Ecological Risk Assessment Process” (U.S. EPA, 2014a) and are
typically based on the most sensitive species tested for each taxon. OPP
grants a registration to allow a pesticide’s distribution, sale, and use only
after the application for registration meets the scientific and regulatory
requirements. These data requirements apply to any person, entity, or
any company that registers pesticides under FIFRA or seeks a tolerance
or tolerance exemption under FFDCA.
In evaluating a pesticide registration application, OPP assesses a
wide variety of potential environmental effects associated with use of
the product. Registrants must generate scientific data necessary to
define properties (e.g., product chemistry, performance, toxicology,
ecological effects, human exposure, spray drift, environmental fate) and
potential adverse effects to a variety of taxonomic groups of organisms
(Table 2). The data allow OPP to evaluate whether a pesticide could
have adverse effects on nontarget organisms and federally listed
threatened or endangered species, including terrestrial and aquatic
vertebrates and invertebrates from exposure as a result of registered uses
of a pesticide.
FIFRA provides EPA with considerable authority to establish or
modify data needs and timing for individual pesticide registration ac
tions to achieve statutory and program objectives. Data requirements for
pesticide registration actions are codified in 40 CFR Part 158 (2012),
informally referred to as “Part 158”. These regulations provide OPP with
substantial discretion to make registration decisions based on what OPP
determines to be the most relevant and important data for each regu
latory action.
The studies required under FIFRA Part 158 provide the scientific
basis for effects characterization to evaluate the potential risks associ
ated with specific pesticide uses. There are additional data “re
quirements” relevant to mandatory screening of pesticides for the
potential for endocrine disruption under FFDCA 408(p)(3) unless a
pesticide is exempted under FFDCA 408(p)(4). Table 2 represents the
general breadth of requirements commonly encountered for registration
decisions. There is considerable flexibility available to OPP in imple
menting Part 158; for example, additional data can be required (Section
158.75), alternative approaches can be accepted, and studies can be
waived (Section 158.45). OPP’s goal is to acquire adequate information
to reliably support pesticide registration decisions that are protective of
human health and the environment. This goal also includes avoiding the
generation and evaluation of data that do not materially influence the
scientific certainty of a regulatory decision and ensuring that highquality science is used to support regulatory decisions while avoiding
unnecessary use of time and resources, data generation costs, and animal
testing. To address these goals OPP staff have been provided with
“Guiding Principles for Data Requirements” to focus on the information
most relevant to the assessment (U.S. EPA, 2013a,b).

2.3.1.2. Office of Pollution Prevention and Toxics. OPPT has authority
under TSCA to regulate the manufacture (including import), processing,
distribution in commerce, use, and disposal of chemical substances
within the United States. OPPT uses data submitted under TSCA to carry
out mandates including risk assessments and risk management activ
ities. In characterizing the hazard of a new or existing chemical sub
stance under specific conditions of use, OPPT considers effects on both
human health and the environment. Special considerations are made for
chemical substances or mixtures predicted to be persistent in the envi
ronment, bioaccumulative, and toxic (PBT). These substances present
unique concerns to ecological species because they can remain in the
environment for long periods of time and can accumulate in organisms.
Certain substances regulated by other U.S. agencies or EPA offices under
the authority of separate federal statutes are excluded from TSCA risk
management, including, among others, color additives, drugs, food, and
pesticides.
The 2016 Frank R. Lautenberg Chemical Safety for the 21st Century
Act amended TSCA (15 U.S.C. § 2601 et seq., 2016) and expanded EPA’s
authority relating to chemical substances. The Lautenberg Act amend
ments require the Agency to:
• Make risk determinations and address identified unreasonable risks
as required for new chemical substances before market entry;
• Prioritize and categorize existing chemical substances as low- or
high-priority substances for risk evaluation;
• Perform risk evaluations on high-priority substances to determine if
they pose an unreasonable risk of injury to health or the
environment;
• Take regulatory action to address the identified unreasonable risks.
TSCA does not require a base set of human health or environmental
effects data to be submitted with a new chemical substance submission
or prior to evaluating risks of existing chemicals. However, TSCA does
give EPA the authority under Section 4 (U.S. EPA, 2014b) to require
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testing or information development, as necessary, for prioritization of
chemicals or to assess risk for new and existing chemicals. Additionally,
under Section 5(e) (U.S. EPA, 2015e), EPA can require testing of a new
chemical substance prior to its commercialization. The types of eco
toxicity data considered most relevant for TSCA risk evaluations include
aquatic toxicity data across several trophic levels (e.g., fish, in
vertebrates, and aquatic plants) and terrestrial toxicity data for at least
two trophic levels (e.g., soil invertebrates and mammalian or avian
species).
An additional legislative mandate added by the 2016 amendments to
TSCA (TSCA Section 4(h)15 U.S.C. § 2603(h), 2016) requires EPA to
consider non-traditional data and to promote the development and
implementation of alternative test methods. Specifically, the amend
ments call for the reduction and replacement, to the extent practical and
scientifically justified, of vertebrate animal use in toxicity testing. EPA is
required to consider existing information before requesting tests using
vertebrate animals (Section 4(h)(1)). While the amended TSCA does not
identify the specific hazards for which animal alternatives should be
considered, Section 4(h)(2)(A) directs EPA to consider NAMs before EPA
requests or requires toxicity testing: 1) computational toxicology and
bioinformatics, 2) high-throughput screening methods, 3) testing of
categories of chemical substances, 4) tiered testing methods, 5) in vitro
(i.e., cell-based) studies, 6) systems biology, 7) new or revised methods
identified by validation bodies such as ICCVAM or the Organisation for
Economic Co-operation and Development (OECD), and 8) industry
consortia that develop similar information or approaches. Consideration
of NAMs in ecological hazard evaluations is ongoing for both new and
existing chemical substances.

associated with aquatic life. From time to time, these criteria, which are
not regulatory, are revised based on the latest scientific knowledge.
States and authorized tribes may adopt EPA CWA Section 304(a) criteria
into their WQS or may adopt their own criteria that differ from EPA’s
recommendations using scientifically defensible methods, subject to
EPA’s approval. States implement EPA-approved criteria as part of their
regulatory WQSs, and exposure is considered by states in permits and
listing decisions.
OW/OST uses available, reliable aquatic toxicity data, including data
found in publicly-available literature and data generated through the
activities of other EPA offices, to develop ambient water quality criteria
(U.S. EPA, 2015f) for aquatic life. These criteria are developed following
procedures in the “Guidelines for Deriving Numerical National Water
Quality Criteria for Protection of Aquatic Organisms” (Stephen et al.,
1985; U.S. EPA, 2015f, 2015i). Acute aquatic life criteria are based on
data for at least eight families of aquatic organisms, three vertebrates
and five invertebrates. Chronic test requirements are of similar scope
with different durations/species. Acute and chronic life data are used by
OW to generate a sensitivity distribution of genus average data to esti
mate criteria that are statistically protective of approximately 95% of
aquatic genera. OST has initiated work to examine the use of NAMS to
address gaps in available data for aquatic life criteria development,
which would reduce the need for animal tests for this purpose.
CWA Section 301 made it unlawful to discharge any pollutant from a
point source into navigable waters unless authorized under a NPDES
permit as provided in CWA Section 402. As required under CWA Section
301(b)(1)(C), NPDES permits must include water quality-based effluent
limitations to implement any applicable state and tribal WQS. To protect
water quality, EPA recommends using “whole effluent toxicity” (WET)
tests in NPDES permits together with requirements based on chemicalspecific water quality criteria (U.S. EPA, 2015f) to ensure that the
state or tribal criteria in the WQS for aquatic life protection are met.
Under the NPDES program WET testing is used to assess whether there
are toxic impacts to aquatic life at a level that would result in an
excursion of state or tribal WQS. As described in 67 FR 69951 (U.S. EPA,
2002), for potentially regulated entities, EPA and authorized states,
territories, and tribes, issue permits that comply with the
technology-based and water quality-based requirements of the CWA. If
EPA has ‘‘approved’’ (i.e., promulgated through rulemaking) standard
ized and promulgated test procedures in 40 CFR Part 136 for a given
pollutant, the NPDES permitting authority must specify one of the
approved testing procedures or must use an EPA-approved alternate test
procedure as directed by the permitting authority (40 CFR Part 122.21
(j)(5), (viii)) for monitoring pollutant discharges as required under a
NPDES permit. Aquatic toxicity test methods designed specifically for
measuring WET (U.S. EPA, 1994a; 1994b, 1993, 1995), the 821 methods
cited herein, are codified in 40 CFR Part 136 (40 CFR 136, 2016; U.S.
EPA, 2002) and employ a suite of standardized freshwater, marine, and
estuarine plants, invertebrates, and vertebrates to estimate acute and
short-term chronic toxicity of effluents and receiving waters (methods
specified in (40 CFR § 136.3(a) - Table IA, 2002; 40 CFR § 136.3(a) Tables II, 2002)).

2.3.2. Office of Water
In the United States, the CWA has been the cornerstone of surface
water quality protection, and OW has three program offices that
implement the CWA. The Office of Science and Technology (OST), the
Office of Wastewater Management (OWM), and the Office of Wetlands,
Oceans and Watersheds (OWOW) that work with states, tribes, and other
stakeholders to help ensure our nation’s waters can be used for fishing,
swimming, and drinking water and can support healthy and sustainable
biological communities. OST does not require ecotoxicity testing but
does manage several programs that utilize ecotoxicity data (i.e., water
quality criteria (U.S. EPA, 2015f, 2013c) and water quality standards
(WQS) (U.S. EPA, 2014c)). OWOW manages the CWA program under
which states develop Total Maximum Daily Loads (TMDLs) for water
bodies and submit them to EPA for review and approval or disapproval.
TMDLs may use water quality criteria in the development of these
TMDLs to ultimately achieve the water quality standards. OWOW also
manages the listing program under CWA Section 303(d), under which
states assemble and evaluate water quality-related data and information
to determine whether water bodies are impaired and require a TMDL
under applicable WQS. OWOW collaborates with states and tribes on
water quality monitoring, supporting state and tribal monitoring and
assessment programs under CWA Sections 106(e) and 305(b) to report
on the extent of waters that support the CWA goal that water quality
provides for healthy biological communities and recreational activities.
OWOW programs do not require use of toxicity testing, but the results
are incorporated into state assessment decisions when available. OWM
oversees a range of programs promoting effective and responsible water
use, treatment, disposal, and management, including the National
Pollutant Discharge Elimination System (NPDES; (U.S. EPA, 2015g,
2014d)) regulatory and permitting program which requires whole
effluent toxicity (WET) testing as part of its monitoring of permitted
effluent discharges for determining the reasonable potential for excur
sions of state or tribal water quality standards (40 CFR Part 122.44(d)
(1), 2003) and NPDES WET permit limit compliance monitoring (40 CFR
Part 122.41(j), 2003).
Under CWA Section 304(a), EPA develops and publishes criteria for
surface waters to protect various designated uses, including those

2.3.3. Directive to reduce animal testing
EPA released its “New Approach Methods Work Plan: Reducing Use
of Animals in Chemical Testing” in June 2020 (U.S. EPA, 2020a), with
an updated version released in December of 2021 (U.S. EPA, 2021). In
this work plan, the Agency described the objectives:
• Evaluate regulatory flexibility for accommodating the use of NAMs;
• Develop baselines and metrics for assessing progress;
• Establish scientific confidence in NAMs and demonstrate application
to regulatory decisions;
• Develop NAMs that fill critical information gaps; and
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• Engage and communicate with stakeholders to incorporate their
knowledge and address concerns as EPA moves away from
mammalian testing.

concentration of different chemicals in environmental samples, for
verifying the performance of an extraction method during ecotoxicity
testing, or for developing NAMs. In addition, NIST has performed
method development and interlaboratory testing to evaluate methods to
quantify contaminants in different matrices. (Reiner et al., 2011;
Schantz et al., 2015; Wise et al., 1988).
In recent years, a concerted effort has focused on developing refer
ence materials and standards related to the potential environmental and
human health risks of nanomaterials. NIST was tasked with developing
these materials and standards as part of the National Nanotechnology
Initiative in 2012 (National Nanotechnology Initiative, 2011). Research
in this area has led to the production of a wide range of reference ma
terials (e.g., gold nanoparticles, silver nanoparticles, single-wall carbon
nanotubes, titanium dioxide nanoparticles, and silicon nanoparticles
(NIST, 2010)). In addition, methods have been developed for quanti
fying different carbon and inorganic (e.g., gold) nanomaterials in
matrices such as soil and water (Bustos et al., 2015; Deng et al., 2017; El
Hadri et al., 2018), and evaluating the release of nanomaterials from
consumer products (Jacobs et al., 2016; Nguyen et al., 2017). The
robustness of ecotoxicology methods (e.g., an ISO C. elegans assay
(Hanna et al., 2018, 2016), OECD test guidelines (Petersen et al., 2015),
and bioaccumulation tests (Bjorkland et al., 2017)) have been rigorously
evaluated with recommended protocols and control tests provided to
identify and minimize potential artifacts. Lastly, a cell viability assay has
been developed and evaluated using an interlaboratory comparison
(Elliott et al., 2017; Rösslein et al., 2015), and is now available as a
standard issued by the International Organization for Standardization
(19007:2018(en) Nanotechnologies — In vitro MTS assay for measuring
the cytotoxic effect of nanoparticles, (ISO, 2018)).

2.4. U.S. Food and Drug Administration
FDA is responsible for protecting the public health by ensuring the
safety, effectiveness, and security of human and veterinary drugs, bio
logical products, and medical devices, and by regulating the safety of
our nation’s food supply, color additives, and products that emit radi
ation. FDA is also responsible for regulating the manufacturing, mar
keting, and distribution of tobacco products, and for reducing tobacco
use by minors. FDA-regulated products account for about 20 cents of
every dollar spent by U.S. consumers (FDA, 2019).
As part of its responsibilities, FDA considers the potential environ
mental effects of agency actions, following policies and procedures set
forth in NEPA and as codified in 21 C.F.R. § 25 (1997). NEPA and its
implementing regulations in 40 CFR Parts 1500-1508 (2011) provide
tools such as the environmental assessment (EA), the environmental
impact statement (EIS), and categorical exclusions (for which neither an
EA nor EIS are required) to evaluate the potential for environmental
impacts. However, NEPA does not strictly specify the methods or ap
proaches used to evaluate potential impacts with these tools. This allows
flexibility for each agency to determine testing requirements based on
the needs of their proposed action(s).
Under NEPA, FDA typically assesses or prepares prospective EAs and
claims of categorical exclusion prior to approval or market authorization
of regulated products (e.g., drugs, biologics, food additives, tobacco
products, medical devices). The overall goal of these assessments is to
determine whether an agency action (e.g., approval and subsequent
marketing of a regulated product) will have a significant impact on the
environment, in which case an EIS is prepared. FDA has published
Guidance for Industry documents (FDA, 2006a; 2006b, 2001, 1998) that
contain recommendations on how to prepare an EA, including data re
quirements and tiered approaches for ecotoxicity testing. These docu
ments recommend the use of validated test methods and guidelines,
many of which are published by the Test Guidelines Programme of the
OECD (Table S2). FDA also accepts the use of other validated test
guidelines, such as those published by EPA. However, FDA guidance
documents are not binding on FDA or the industry, and FDA often
considers alternative approaches on a case-by-case basis. Findings ob
tained through use of alternative methods, including NAMs (e.g., in
chemico, in silico, or in vitro assays), need to be correlated to an apical or
population-level endpoint (e.g., mortality, growth, or reproduction) for
the data to be used in regulatory risk assessments. FDA also encourages
the use of published literature, when available, in place of original
laboratory studies. Generally, multiple independent literature studies
with adequate methods, analyses, and consistent findings should be
provided to replace a validated and well-controlled laboratory study
conducted under Good Laboratory Practices (40 CFR § 160, 2002).
Some alternative methods are currently being used in limited cases.
For instance, the FDA Center for Drug Evaluation and Research may
consider alternative methods on a case-by-case basis to screen human
drugs for possible endocrine-active signals in the environment (FDA,
2016).

2.6. U.S. Department of Agriculture
Like other federal agencies, USDA must comply with all relevant
environmental statutes related to actions they may fund, authorize, or
regulate. USDA uses ecotoxicology data primarily to meet its regulatory
requirements under these environmental statutes (Table 1). Compliance
under NEPA includes the preparation of EAs, EISs, and categorical ex
clusions. The evaluation of USDA actions under these three processes
can include the use of ecological toxicity data to determine the extent of
potential effects to fish and wildlife from a proposed action by a USDA
agency. In addition, the ESA requires the use of ecotoxicology data to
determine if an action proposed by USDA could impact a listed species.
The data used in these types of analyses include measuring effects in
nontarget fish and wildlife from chemical and non-chemical stressors.
These data may originate as part of a regulatory requirement or are
obtained from publicly available peer-reviewed journals and other
published documents.
The USDA Animal and Plant Health Inspection Service (APHIS) is a
registrant for several types of compounds for control of pest species (e.g.,
avicides, rodenticides) that require the development of ecotoxicology
data for registration under FIFRA. Data submissions that characterize
the effects of a pesticide to nontarget fish and wildlife are required as
part of the FIFRA evaluation process under EPA OPP when registering a
pesticide.
The USDA Forest Service National Technology and Development
Program evaluates and qualifies wildland fire suppressants and re
tardants. Once a fire chemical meets all Forest Service (FS) re
quirements, it is added to a Qualified Products List (QPL) and becomes
available for use by federal wildland firefighting agencies. The evalua
tion requires the development of mammalian and aquatic toxicity data
for use in risk assessments and environmental consultation tied to the
required Environmental Impact Statement on aerially-applied fire
retardant. These studies are conducted by other third-party laboratories.
Both APHIS and FS prepare human health and ecological risk as
sessments for proposed pesticide use for many of its programs. Court
decisions in the 1980’s required the FS to perform risk assessments

2.5. National Institute of standards and technology
NIST is regularly involved in the development of reference materials,
test methods, and documentary standards that support other agencies
with fulfilling ecotoxicity testing needs. For example, NIST has produced
a broad range of standard reference materials for samples from various
environmental media (e.g., sewage sludge, soil, sediment, water (NIST,
2010)), and has quantified the concentration of various organic and
inorganic pollutants in these matrices. These materials can be used as
part of a quality control system for laboratories that are testing the
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particular to USDA’s proposed uses, beyond those conducted by EPA for
pesticide registrations. These risk assessments use available ecological
toxicity testing data available through the pesticide registration process
or available in the peer-reviewed literature and other publicly available
documents, to make estimates about risk to terrestrial and aquatic
nontarget fish and wildlife for pesticides and other chemicals that may
be used in specific agency activities.
USDA may also use and develop ecotoxicology-related data as part of
its research activities. One example is the Agricultural Research Service
(ARS). The ARS is divided into four program areas that address 1)
Nutrition, Food Safety and Quality, 2) Animal Production and Protec
tion, 3) Crop Production and Protection, and 4) Natural Resources and
Sustainable Agricultural Systems. Within each program, ARS supports
research efforts to evaluate a wide variety of topics related to agricul
ture. As an example, in studies to determine impacts and identify solu
tions concerning bee exposure to multiple agrochemicals, ARS uses the
expertise of environmental chemists along with data from EPA to
develop and validate models of pesticide movement from nest-building
materials into the nectar and pollen stores used to feed larvae.
The ARS also uses ecological-related effects data to characterize how
various land and agricultural management practices can impact the
environment, including fish and wildlife.
The USDA actively promotes and supports the use of alternatives to
live animal use. For example, the APHIS National Wildlife Research
Center (NWRC) uses alternate in vitro techniques to replace animal
testing such as assessing metabolic pathways using liver microsomes.
The NWRC also uses data generated from proteomic, metabolomic, and
genetic databases, and computer modelling to meet research needs as
alternatives to animal testing.
The Animal Welfare Information Center (AWIC), which is located
within ARS′ National Agricultural Library, was designated in 1985
under the AWA to serve as a resource to assist investigators in finding
alternatives to animal testing. AWIC provides training in conducting
literature searches for alternatives, specifically searches for in silico, in
chemico, or in vitro techniques using a plethora of databases (USDA,
2021a). AWIC’s services are provided at no cost and are available to all
members of the research community. In addition, the AWIC website
provides a list of peer-reviewed publications on alternatives to animal
testing and other guidance designed to reduce, replace, and refine eco
toxicity testing using animals (USDA, 2021b).

expected difference in the relative sensitivity to the toxicant among the
untested species. Under current data sets dependent upon in vivo testing,
accounting for these interspecies differences is accomplished by several
approaches:
• Reliance on the most sensitive species tested;
• Application of generic interspecies adjustment factors to available
data sets derived from only a few species to approximate some level
of protection based on a fixed position on the distribution of possible
outcomes; or
• Application of chemical-specific species sensitivity distributions
derived from larger multiple-species testing data sets.
Limiting assumptions for these approaches have been outlined by
Forbes and Forbes (1993) and Forbes and Calow (2002), and include:
• The distribution of species sensitivities in natural ecosystems closely
approximates the postulated theoretical distribution;
• The sensitivity of species used in laboratory tests provides a measure
of the variability and range of the sensitivity distribution of species in
natural communities;
• By protecting species composition, community function is also pro
tected, and
• Interactions among species in communities/ecosystems can be
ignored.
However, it should be noted that extrapolating data generated from
laboratory animals to a broader suite of organisms in the environment
has known uncertainties, including:
• Laboratory animal species may not exhibit the full suite of toxic ef
fects of interest for the target species. For example, the protocols of
routine studies with precocial bird species (e.g., Ecological Effects
Test Guidelines OCSPP 850.2300 (U.S. EPA, 2012)) do not evaluate
potential effects of behavioral endpoints such as nest building,
complex courtship behavior, egg incubation, and care of hatchlings.
It is possible such studies are incomplete predictors of reproduction
hazard for wild birds especially altricial species where many of the
behaviors are critical to offspring production (Ar and Yom-Tov,
1978);
• Laboratory animals may not have the same sensitivity to toxicants as
the species of interest (Brown et al., 2009);
• Laboratory animals may not occupy the same taxa or ecological
niche, or may not have the same life cycles as the species of interest
(Brown et al., 2014);
• Model organisms may be chosen for conveniences such as ease and
low-cost of maintenance, rapid development, and high fecundity,
rather than for appropriateness of the surrogate species (i.e., func
tional homologies or toxicity relevant traits with the species of
concern (Segner- and Baumann, 2016));
• Single-species laboratory tests using model organisms with limited
genetic variability (Brown et al., 2009) do not reflect the genetic
heterogeneity of wild populations;
• Tests on laboratory animals may not be able to accurately predict
ecosystem responses (Cairns, 1988).

3. Discussion
The preceding sections provide a synopsis of regulatory and nonregulatory testing needs of ICCVAM agencies for ecotoxicology testing
data, which are still largely fulfilled by data from animal testing. Thus,
replacing animal testing for ecotoxicology endpoints remains a longterm goal. While agencies work towards the long-term goal of replace
ment, opportunities exist to improve the utility of currently obtained
data and reduce animal use by improving understanding of toxicity
mechanisms and implementing testing waivers.
3.1. Challenges with cross-taxa and interspecies extrapolation
Consideration of the need and in some cases regulatory requirements
for tests in Table 2, and the associated taxa employed in these specific
test guidelines, suggest that there is a relatively narrow selection of
surrogate test species being used to represent a large assemblage of
species organized in relatively broad taxonomic groups. For example,
data from the medaka one-generation test is extrapolated out to hun
dreds of other ray-finned fish species, and reproduction toxicity data for
two species of precocial birds is used to make hazard inferences for all
the precocial and altricial birds in North America. There are a number of
technical, legal, historical, logistical, and financial reasons why only a
few species of a given taxa are ever tested (Lillicrap et al., 2016). A
challenge for the use of such data across a given taxonomic group is the

Advances in bioinformatics and the development of the concept of
adverse outcome pathways (Ankley et al., 2010; Ellison et al., 2016;
Jeong and Choi, 2017; Vinken et al., 2017) could be applied to
strengthen the inferences made in ecotoxicity extrapolations by devel
oping lines of evidence such as:
• An understanding of the genetic and biochemical evidence appli
cable to the uptake, distribution, and metabolic activation/inacti
vation of a given toxicant across the genetic variation among species
within given taxa;
9
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• Mechanism-of-action data relative to specific genetic inductions or
receptor affinities and the resultant pathway to adverse outcomes;
and
• The conservation of adverse outcome pathways across taxa, which
can be explored using approaches in bioinformatics like EPA
Sequence Alignment to Predict Across Species Susceptibility tool
(LaLone et al., 2016).

develop metrics for assessing progress in NAM development and use. In
order to facilitate this process, in early 2020, ICCVAM established a
Metrics Workgroup to identify ways to help the committee and its
member agencies better monitor their progress across the range of their
efforts to reduce animal use and report members’ progress to the public.
A report is available6 that describes the recommendations of the Metrics
Workgroup and provides resources that can be used to follow federal
agency progress.
The diversity of agency testing needs coupled with the biological
complexity of vertebrates makes it unlikely that a single animal test can
be replaced with a single alternative test. Each federal agency must
evaluate replacement methods in the context of program needs to
determine the extent to which each method provides information
equivalent to the whole animal test targeted for replacement. For
example, validating approaches that extrapolate in vitro or in silico re
sults to population-level effects may prove to be a challenge in some
cases. Similarly, new animal assays, such as the medaka extended one
generation reproduction test (OECD, 2015; U.S. EPA, 2015h), represent
a challenge to NAMs development in that they introduce new ecological
effects endpoints for consideration in regulatory decision-making.
Continued development of animal assays may add to the list of animal
methods that are potential candidates for replacement and may expand
the complexity of analyses needed to support the move to use in silico
and in vitro assays. However, the examples described herein demonstrate
that agencies are motivated to identify opportunities to implement al
ternatives to animal testing in appropriate contexts. The EcoWG and
participating agencies will monitor advances already realized in the
context of human health protection (ICCVAM, 2020) to determine their
applicability to ecotoxicity testing. Future EcoWG activities include
preparation of a review of available and applicable NAMs for acute fish
toxicity testing to justify its immediate prioritization as a target for
replacement.

Further, in silico methods to predict toxic effects will provide addi
tional valuable information with respect to these lines of evidence
important to cross-taxa extrapolation (Eng et al., 2017; Fuchsman et al.,
2017; U.S. EPA, 2016a).
3.2. Waiving the need for certain ecotoxicity test data
Although few in vitro, in silico, or in chemico NAMs exist that have
been assessed or routinely used to fully replace the use of animals for
ecotoxicity testing, there are circumstances where the need for in vivo
data for certain ecotoxicity tests can be waived, resulting in the reduc
tion of animal use. Some circumstances where waivers may be used are
described below.
Registrants of chemicals can request a waiver of data requirements or
can bridge information from one data set to another. Waiver submissions
must specify the data requirement for which a waiver is being sought
and must include the supporting rationale why the requirement should
be waived. Waiver requests can include suggestions for alternate means
of obtaining the data. These actions create the opportunity to reduce
animal use (U.S. EPA, 2020b) and avoid generating data that are not
needed or are available through other means while still ensuring that
regulatory decisions are suitably informed. For example, a retrospective
analysis of avian acute-oral and sub-acute dietary test data for pesticide
registration by EPA demonstrated that risk quotients used in
decision-making were almost exclusively derived (>99%) from acute
oral test (Hilton et al., 2019). Based on this analysis, EPA released
guidance in April 2020 (U.S. EPA, 2020c) stating that the sub-acute
avian dietary test requirement can be waived when deemed to provide
little additional scientific information for environmental or public
health. Likewise, fish bioconcentration test guidelines historically
required that bioconcentration factors (BCFs) be determined at two
exposure concentrations. Analysis of 236 fish BCF studies revealed that
estimates did not differ significantly when more than one test concen
tration was used (Burden et al., 2014), and thus if the BCF value is less
than or equal to 667, adequate BCF data may be obtained using one test
concentration, as described in “Fish Bioconcentration Data Require
ment: Guidance for Selection of Number of Treatment Concentrations.”
(U.S. EPA, 2020d), a supplement to EPA 850.1730 (U.S. EPA, 2016b).
In some instances, federal agencies may waive the need for ecotox
icity tests when existing data for risk assessment and regulatory de
cisions are adequate (e.g., DOI, approval of candidate shot and shotcoatings used in hunting of waterfowl [Sec. 2.2]; FDA approval of
human and veterinary drugs [Sec. 2.4]). Use of these waivers decreases
animal usage by reducing the number of required tests.
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The breadth of data needed to support U.S. Federal ecological riskbased decisions varies with each program. The ICCVAM EcoWG has
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agencies, academia, the regulated community, and other national, state,
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animals in ecological testing. The participating agencies have highly
divergent needs ranging from chemical testing regimes, to water quality
assessments for statutory regulatory requirements, to more specific
scenario-based understandings to evaluate the potential impact of an
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ural resource damage. These divergent needs make it challenging to
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